This is a non-competitive opportunity for preventive maintenance services on a government-owned 700 MHz NMR instrument, essential for cancer research at the National Cancer Institute. The contract is intended to be awarded to Bruker Biospin Corporation, the only authorized provider of OEM parts and manufacturer-specified service. Onsite services will be performed at 37 Convent Dr., Bldg 37, Room B134, Bethesda, MD 20814. The anticipated period of performance is from May 22, 2026, through May 21, 2031. No budget amount is specified.